Found 4 hits for monomerid = 50281984 Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Cholecystokinin receptor type A
(RAT) | BDBM50281984
((S)-3-[(Z)-2-(Adamantan-2-yloxycarbonylamino)-3-(1...)Show SMILES OC(=O)C[C@H](Cc1ccccc1)NC(=O)C(Cc1c[nH]c2ccccc12)=NC(=O)OC1C2CC3CC(C2)CC1C3 |w:26.29,wD:4.12,TLB:36:31:39:35.37.34,36:35:30.31.32:39,THB:34:35:30:33.32.39,34:33:30:35.37.36,29:30:39:35.37.34,(11.61,.81,;12.26,-.59,;13.77,-.8,;11.3,-1.8,;11.86,-3.24,;13.38,-3.45,;14.8,-2.8,;14.94,-1.29,;16.33,-.64,;17.59,-1.52,;17.45,-3.08,;16.05,-3.71,;10.91,-4.43,;9.39,-4.22,;8.81,-2.78,;8.44,-5.41,;6.92,-5.2,;5.97,-6.41,;6.39,-7.9,;5.08,-8.76,;3.87,-7.79,;2.36,-8.04,;1.38,-6.85,;1.92,-5.41,;3.43,-5.15,;4.41,-6.34,;9,-6.85,;10.44,-7.39,;10.51,-8.93,;11.84,-6.74,;13.1,-7.65,;13.07,-9.35,;14.56,-9.93,;15.84,-9.25,;15.19,-10.58,;13.61,-10.04,;12.42,-10.56,;13.63,-8.09,;14.54,-6.92,;15.84,-7.69,)| Show InChI InChI=1S/C32H35N3O5/c36-29(37)17-25(15-19-6-2-1-3-7-19)34-31(38)28(16-24-18-33-27-9-5-4-8-26(24)27)35-32(39)40-30-22-11-20-10-21(13-22)14-23(30)12-20/h1-9,18,20-23,25,30,33H,10-17H2,(H,34,38)(H,36,37)/t20?,21?,22?,23?,25-,30?/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article
| n/a | n/a | 18 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description Compound measured for half-maximal inhibition of specific binding of [125I]-Bolton Hunter CCK-26-33 to CCK-A receptor in the rat pancreas. |
Bioorg Med Chem Lett 3: 989-992 (1993)
Article DOI: 10.1016/S0960-894X(00)80273-5 BindingDB Entry DOI: 10.7270/Q2XD11M0 |
More data for this Ligand-Target Pair | |
Gastrin/cholecystokinin type B receptor
(MOUSE) | BDBM50281984
((S)-3-[(Z)-2-(Adamantan-2-yloxycarbonylamino)-3-(1...)Show SMILES OC(=O)C[C@H](Cc1ccccc1)NC(=O)C(Cc1c[nH]c2ccccc12)=NC(=O)OC1C2CC3CC(C2)CC1C3 |w:26.29,wD:4.12,TLB:36:31:39:35.37.34,36:35:30.31.32:39,THB:34:35:30:33.32.39,34:33:30:35.37.36,29:30:39:35.37.34,(11.61,.81,;12.26,-.59,;13.77,-.8,;11.3,-1.8,;11.86,-3.24,;13.38,-3.45,;14.8,-2.8,;14.94,-1.29,;16.33,-.64,;17.59,-1.52,;17.45,-3.08,;16.05,-3.71,;10.91,-4.43,;9.39,-4.22,;8.81,-2.78,;8.44,-5.41,;6.92,-5.2,;5.97,-6.41,;6.39,-7.9,;5.08,-8.76,;3.87,-7.79,;2.36,-8.04,;1.38,-6.85,;1.92,-5.41,;3.43,-5.15,;4.41,-6.34,;9,-6.85,;10.44,-7.39,;10.51,-8.93,;11.84,-6.74,;13.1,-7.65,;13.07,-9.35,;14.56,-9.93,;15.84,-9.25,;15.19,-10.58,;13.61,-10.04,;12.42,-10.56,;13.63,-8.09,;14.54,-6.92,;15.84,-7.69,)| Show InChI InChI=1S/C32H35N3O5/c36-29(37)17-25(15-19-6-2-1-3-7-19)34-31(38)28(16-24-18-33-27-9-5-4-8-26(24)27)35-32(39)40-30-22-11-20-10-21(13-22)14-23(30)12-20/h1-9,18,20-23,25,30,33H,10-17H2,(H,34,38)(H,36,37)/t20?,21?,22?,23?,25-,30?/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article
| n/a | n/a | 0.300 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description Compound measured for half-maximal inhibition of specific binding of [125I]-Bolton Hunter CCK-26-33 to CCK-A receptor in the rat pancreas. |
Bioorg Med Chem Lett 3: 989-992 (1993)
Article DOI: 10.1016/S0960-894X(00)80273-5 BindingDB Entry DOI: 10.7270/Q2XD11M0 |
More data for this Ligand-Target Pair | |
Cholecystokinin receptor type A
(RAT) | BDBM50281984
((S)-3-[(Z)-2-(Adamantan-2-yloxycarbonylamino)-3-(1...)Show SMILES OC(=O)C[C@H](Cc1ccccc1)NC(=O)C(Cc1c[nH]c2ccccc12)=NC(=O)OC1C2CC3CC(C2)CC1C3 |w:26.29,wD:4.12,TLB:36:31:39:35.37.34,36:35:30.31.32:39,THB:34:35:30:33.32.39,34:33:30:35.37.36,29:30:39:35.37.34,(11.61,.81,;12.26,-.59,;13.77,-.8,;11.3,-1.8,;11.86,-3.24,;13.38,-3.45,;14.8,-2.8,;14.94,-1.29,;16.33,-.64,;17.59,-1.52,;17.45,-3.08,;16.05,-3.71,;10.91,-4.43,;9.39,-4.22,;8.81,-2.78,;8.44,-5.41,;6.92,-5.2,;5.97,-6.41,;6.39,-7.9,;5.08,-8.76,;3.87,-7.79,;2.36,-8.04,;1.38,-6.85,;1.92,-5.41,;3.43,-5.15,;4.41,-6.34,;9,-6.85,;10.44,-7.39,;10.51,-8.93,;11.84,-6.74,;13.1,-7.65,;13.07,-9.35,;14.56,-9.93,;15.84,-9.25,;15.19,-10.58,;13.61,-10.04,;12.42,-10.56,;13.63,-8.09,;14.54,-6.92,;15.84,-7.69,)| Show InChI InChI=1S/C32H35N3O5/c36-29(37)17-25(15-19-6-2-1-3-7-19)34-31(38)28(16-24-18-33-27-9-5-4-8-26(24)27)35-32(39)40-30-22-11-20-10-21(13-22)14-23(30)12-20/h1-9,18,20-23,25,30,33H,10-17H2,(H,34,38)(H,36,37)/t20?,21?,22?,23?,25-,30?/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article
| n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description Compound measured for half-maximal inhibition of specific binding of [125I]-Bolton Hunter CCK-26-33 to CCK-A receptor in the rat pancreas. |
Bioorg Med Chem Lett 3: 989-992 (1993)
Article DOI: 10.1016/S0960-894X(00)80273-5 BindingDB Entry DOI: 10.7270/Q2XD11M0 |
More data for this Ligand-Target Pair | |
Gastrin/cholecystokinin type B receptor
(MOUSE) | BDBM50281984
((S)-3-[(Z)-2-(Adamantan-2-yloxycarbonylamino)-3-(1...)Show SMILES OC(=O)C[C@H](Cc1ccccc1)NC(=O)C(Cc1c[nH]c2ccccc12)=NC(=O)OC1C2CC3CC(C2)CC1C3 |w:26.29,wD:4.12,TLB:36:31:39:35.37.34,36:35:30.31.32:39,THB:34:35:30:33.32.39,34:33:30:35.37.36,29:30:39:35.37.34,(11.61,.81,;12.26,-.59,;13.77,-.8,;11.3,-1.8,;11.86,-3.24,;13.38,-3.45,;14.8,-2.8,;14.94,-1.29,;16.33,-.64,;17.59,-1.52,;17.45,-3.08,;16.05,-3.71,;10.91,-4.43,;9.39,-4.22,;8.81,-2.78,;8.44,-5.41,;6.92,-5.2,;5.97,-6.41,;6.39,-7.9,;5.08,-8.76,;3.87,-7.79,;2.36,-8.04,;1.38,-6.85,;1.92,-5.41,;3.43,-5.15,;4.41,-6.34,;9,-6.85,;10.44,-7.39,;10.51,-8.93,;11.84,-6.74,;13.1,-7.65,;13.07,-9.35,;14.56,-9.93,;15.84,-9.25,;15.19,-10.58,;13.61,-10.04,;12.42,-10.56,;13.63,-8.09,;14.54,-6.92,;15.84,-7.69,)| Show InChI InChI=1S/C32H35N3O5/c36-29(37)17-25(15-19-6-2-1-3-7-19)34-31(38)28(16-24-18-33-27-9-5-4-8-26(24)27)35-32(39)40-30-22-11-20-10-21(13-22)14-23(30)12-20/h1-9,18,20-23,25,30,33H,10-17H2,(H,34,38)(H,36,37)/t20?,21?,22?,23?,25-,30?/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article
| n/a | n/a | 13 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description Compound measured for half-maximal inhibition of specific binding of [125I]-Bolton Hunter CCK-26-33 to CCK-B receptor in the mouse cerebral cortex. |
Bioorg Med Chem Lett 3: 989-992 (1993)
Article DOI: 10.1016/S0960-894X(00)80273-5 BindingDB Entry DOI: 10.7270/Q2XD11M0 |
More data for this Ligand-Target Pair | |